Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology

A. Poliakov, M. Cotrina, D. G. Wilkinson, Diverse roles of eph receptors and ephrins within the regulation of cell migration and tissue assembly. Dev. Cell 7465–480 (2004).

T. K. Niethamer, J. O. Bush, Getting direction(s): The Eph/ephrin signaling machine in cell positioning. Dev. Biol. 44742–57 (2019).

K. K. Murai, E. B. Pasquale, ’Eph’ective signaling: Forward, reverse and crosstalk. J. Cell Sci. 1162823–2832 (2003).

T. K. Darling, T. J. Lamb, Emerging roles for Eph receptors and ephrin ligands in immunity. Entrance. Immunol. 101473 (2019).

J. Egea, R. Klein, Bidirectional Eph-ephrin signaling throughout axon steering. Traits Cell Biol. 17230–238 (2007).

K. O. Lai, N. Y. Ip, Synapse sort and plasticity: Roles of ephrin/Eph receptor signaling. Curr. Opin. Neurobiol. 19275–283 (2009).

K. Ellis, D. Munro, J. Clarke, Endometriosis is undervalued: A call to action. Entrance. Glob. Womens Health 3902371 (2022).

L. Saavalainen et al., Be troubled of gynecologic cancer in accordance to the form of endometriosis. Obstet. Gynecol. 1311095–1102 (2018).

P. Vercellini, P. Vigano, E. Somigliana, L. Fedele, Endometriosis: Pathogenesis and treatment. Nat. Rev. Endocrinol. 10261–275 (2014).

C. To et al., Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that helps vascular development. PLoS One 9e112106 (2014).

H. Fujiwara et al., Promoting roles of embryonic indicators in embryo implantation and placentation in cooperation with endocrine and immune techniques. Int. J. Mol. Sci. 211885 (2020).

Y. Fu, J. Fu, Q. Ren, X. Chen, A. Wang, Expression of Eph A molecules throughout swine embryo implantation. Mol. Biol. Safe. 392179–2185 (2012).

Y. Fu et al., Investigation of Eph-ephrin A1 within the regulation of embryo implantation in sows. Reprod. Domest. Anim. Fifty three1563–1574 (2018).

H. Fujii et al., Eph-ephrin A machine regulates murine blastocyst attachment and spreading. Dev. Man. 2353250–3258 (2006).

A. A. Kamat et al., EphA2 overexpression is associated with lack of hormone receptor expression and unfortunate in endometrial cancer. Cancer 1152684–2692 (2009).

L. D. Dong et al., Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma. Oncol. Lett. 132109–2114 (2017).

I. Psilopatis, A. Pergaris, K. Vrettou, G. Tsourouflis, S. Theocharis, The EPH/Ephrin machine in gynecological cancers: Focusing on the roots of carcinogenesis for better patient administration. Int. J. Mol. Sci. 233249 (2022).

A. V. Buensuceso et al., Ephrin-A5 is required for optimal fertility and a entire ovulatory response to gonadotropins within the female mouse. Endocrinology 157942–955 (2016).

R. Hudecek, B. Kohlova, I. Siskova, M. Piskacek, A. Knight, Blockading of EphA2 on endometrial tumor cells reduces susceptibility to Vdelta1 gamma-delta T-cell-mediated killing. Entrance. Immunol. 12752646 (2021).

E. A. Adu-Gyamfi et al., Ephrin and Eph receptor signaling in feminine reproductive physiology and pathologydagger. Biol. Reprod. 10471–82 (2021).

E. B. Pasquale, Eph receptors and ephrins in cancer: Bidirectional signalling and beyond. Nat. Rev. Cancer 10165–180 (2010).

N. J. Balamuth, R. B. Womer, Ewing’s sarcoma. Lancet Oncol. 11184–192 (2010).

M. Sainz-Jaspeado et al., EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF manufacturing and depends on caveolin-1. PLoS One 8e71449 (2013).

G. Giordano et al., EphA2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived units of osteosarcoma, Ewing’s sarcoma and chondrosarcoma. Cells 102893 (2021).

N. Cheng et al., Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors. Neoplasia 5445–456 (2003).

P. Dobrzanski et al., Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist. Cancer Res. 64910–919 (2004).

N. Cheng et al., Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell development part-induced angiogenesis. Mol. Cancer Res. 12–11 (2002).

L. W. Noblitt et al., Decreased tumorigenic attainable of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that categorical EphrinA1. Cancer Gene Ther. 11757–766 (2004).

Noren NK, Lu M, Freeman AL, Koolpe M, Pas EB quale, Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor development. Proc. Natl. Acad. Sci. U.S.A. 1015583–5588 (2004).

M. Koolpe, M. Dail, E. B. Pasquale, An ephrin mimetic peptide that selectively targets the EphA2 receptor. J. Biol. Chem. 27746974–46979 (2002).

M. W. Karaman et al., A quantitative diagnosis of kinase inhibitor selectivity. Nat. Biotechnol. 26127–132 (2008).

L. Qiao et al., Construction-exercise relationship secret agent of EphB3 receptor tyrosine kinase inhibitors. Bioorg Med. Chem. Easy. 196122–6126 (2009).

Y. Choi et al., Discovery and structural diagnosis of Eph receptor tyrosine kinase inhibitors. Bioorg Med. Chem. Easy. 194467–4470 (2009).

RM Franzini, D. Neri, J. Scheuermann, DNA-encoded chemical libraries: Advancing beyond historical small-molecule libraries. Acc Chem. Res. 471247–1255 (2014).

Y. K. Sunkari, V. K. Siripuram, T. L. Nguyen, M. Flajolet, Excessive-strength screening (HPS) empowered by DNA-encoded libraries. Traits Pharmacol. Sci. 434–15 (2022).

AL Satz et al., DNA-encoded chemical libraries. Nat. Rev. Ideas Primers 23 (2022).

A. Gironda-Martinez, E. J. Donckele, F. Samain, D. Neri, DNA-encoded chemical libraries: A entire assessment with succesful tales and future challenges. ACS Pharmacol. Transl. Sci. 41265–1279 (2021).

J. C. Faver et al., Quantitative comparability of enrichment from DNA-encoded chemical library picks. ACS Comb. Sci. 2175–82 (2019).

J. Zhang, L. Wang, Q. Ji, F. Liu, DNA-Suitable cyanomethylation of (hetero)aryl halides or triflates under a tandem reaction for DNA-encoded library synthesis. Org. Lett. 256931–6936 (2023).

Z. Yu et al., Discovery and characterization of bromodomain 2-dispute inhibitors of BRDT. Proc. Natl. Acad. Sci. U.S.A. 118e2021102118 (2021).

R. K. Modukuri et al., Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library picks. Proc. Natl. Acad. Sci. U.S.A. 119e2122506119 (2022).

R. K. Modukuri et al., Discovery of extremely potent and BMPR2-selective kinase inhibitors using DNA-encoded chemical library screening. J. Med. Chem. 662143–2160 (2023).

R. Jimmidi et al., DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 valuable protease inhibitors. Commun. Chem. 6164 (2023).

M. Gabriel et al., A relational database to title differentially expressed genes within the endometrium and endometriosis lesions. Sci. Files 7284 (2020).

J. S. Tamaresis et al., Molecular classification of endometriosis and disease stage using excessive-dimensional genomic data. Endocrinology 1554986–4999 (2014).

M. I. Kurki et al., FinnGen provides genetic insights from a effectively-phenotyped isolated population. Nature 613508–518 (2023).

M. A. Fabian et al., A tiny molecule-kinase interaction blueprint for medical kinase inhibitors. Nat. Biotechnol. 23329–336 (2005).

A. Zeitvogel, R. Baumann, A. Starzinski-Powitz, Identification of an invasive, N-cadherin-expressing epithelial cell kind in endometriosis using a brand original cell tradition model. Am. J. Pathol. 1591839–1852 (2001).

J. Arnold et al., Imbalance between sympathetic and sensory innervation in peritoneal endometriosis. Mind Behav. Immun. 26132–141 (2012).

V. Anaf et al., Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum. Reprod. 151744–1750 (2000).

B. D. McKinnon, D. Bertschi, N. A. Bersinger, M. D. Mueller, Inflammation and nerve fiber interaction in endometriotic pain. Traits Endocrinol. Metab 261–10 (2015).

Induction of COX-2 and PGE(2) biosynthesis by IL-1beta is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br. J. Pharmacol. 131152–159 (2000).

T. Takahashi, Organoids for drug discovery and personalized medication. Annu. Rev. Pharmacol. Toxicol. 59447–462 (2019).

M. Y. Turco et al., Long-interval of time, hormone-responsive organoid cultures of human endometrium in a chemically defined medium. Nat. Cell Biol. 19568–577 (2017).

Y. Hibaoui, A. Feki, Organoid units of human endometrial sort and disease. Entrance Cell Dev. Biol. 884 (2020).

M. Boretto et al., Constructing of organoids from mouse and human endometrium exhibiting endometrial epithelium physiology and long-interval of time expandability. Constructing 1441775–1786 (2017).

N. I. Herath et al., Over-expression of Eph and ephrin genes in stepped forward ovarian cancer: Ephrin gene expression correlates with shortened survival. BMC Cancer 6144 (2006).

L. Han et al., The medical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas. Gynecol. Oncol. Ninety 9278–286 (2005).

X. Liu et al., EphA8 is a prognostic marker for epithelial ovarian cancer. Oncotarget 720801–20809 (2016).

G. Berclaz et al., Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma. Ann. Oncol. 14220–226 (2003).

S. M. Alam, J. Fujimoto, I. Jahan, E. Sato, T. Tamaya, Overexpression of ephrinB2 and EphB4 in tumor sort of uterine endometrial cancers. Ann. Oncol. 18485–490 (2007).

W. M. Merritt et al., Clinical and biological affect of EphA2 overexpression and angiogenesis in endometrial cancer. Cancer Biol. Ther 101306–1314 (2010).

S. Reinartz et al., A transcriptome-essentially essentially essentially based global blueprint of signaling pathways within the ovarian cancer microenvironment associated with medical . Genome Biol. 17108 (2016).

P. H. Thaker et al., EphA2 expression is associated with aggressive functions in ovarian carcinoma. Clin. Cancer Res. 105145–5150 (2004).

H. Fujii, H. Fujiwara, A. Horie, Y. Sato, I. Konishi, Ephrin A1 induces intercellular dissociation in Ishikawa cells: Most likely implication of the Eph-ephrin A machine in human embryo implantation. Hum. Reprod. 26299–306 (2011).

Y. Yang, J. Min, Attain of ephrin-A1/EphA2 on invasion of trophoblastic cells. J. Huazhong Univ. Sci. Technol. Med. Sci. 31824–827 (2011).

H. Fujiwara et al., Eph-ephrin A machine regulates human choriocarcinoma-derived JEG-3 cell invasion. Int. J. Gynecol. Cancer 23576–582 (2013).

X. Y. Yang, W. J. Zhu, H. Jiang, Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells by project of focal adhesion kinase dephosphorylation. Mol. Cell Biochem. 361259–265 (2012).

H. Jiang, X. Y. Yang, W. J. Zhu, Dysregulated erythropoietin-producing hepatocellular receptor A2 (EphA2) is thinking tubal being pregnant by project of regulating cell adhesion of the Fallopian tube epithelial cells. Reprod. Biol. Endocrinol. 1684 (2018).

Y. Zhang et al., Elevated ranges of hypoxia-inducible microRNA-210 in pre-eclampsia: Novel insights into molecular mechanisms for the disease. J. Cell Mol. With. 16249–259 (2012).

W. Wang et al., Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that specialise in ephrin-B2 and EPHB4 in human placenta. J. Clin. Endocrinol. Metab. 97E1051–1059 (2012).

N. Ilan, J. A. Madri, Novel paradigms of signaling within the vasculature: Ephrins and metalloproteases. Curr. Opin. Biotechnol. 10536–540 (1999).

L. Schrödinger, Schrödinger Release 2022–1 (Schrödinger LLC, Novel York, NY, 2022).

L. Schrödinger, Schrödinger Release 2022–1: LigPrep (Schrödinger, LLC, Novel York, NY, 2022).

R. C. Johnston et al., Epik: pK(a) and protonation affirm prediction through machine discovering out. J. Chem. Thought Comput. 192380–2388 (2023).

R. A. Friesner et al., Extra precision slip with the movement: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem. 496177–6196 (2006).

L. Schrödinger, Schrödinger Release 2023–4: Maestro (Schrödinger, LLC, Novel York, NY, 2022).

T. Yang et al., Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model. J. Hepatol. 751420–1433 (2021).

C. A. Schneider, W. S. Rasband, K. W. Eliceiri, NIH Image to ImageJ: 25 years of image diagnosis. Nat. Ideas 9671–675 (2012).

H. C. Fitzgerald, P. Dhakal, S. K. Behura, D. J. Schust, T. E. Spencer, Self-renewing endometrial epithelial organoids of the human uterus. Proc. Natl. Acad. Sci. U.S.A. 11623132–23142 (2019).